Eveline den Biezen - Timmermans

Eveline den Biezen - Timmermans is a Chief Scientific Officer and Chief Technology Officer at InnoSIGN, where Eveline is responsible for commercializing a proprietary mRNA-based technology called OncoSIGNal. Prior to this, Eveline held various roles at Philips, including Head of Product Development and Services OncoSignal. Eveline has a background in biochemistry and has extensive experience in developing diagnostic assays for personalized cancer treatment and clinical trials coordination.